Description
Quay Pharma is a contract development manufacturing organization (CDMO) that specialises in the development of innovative new entities for biotech companies globally. With a strong focus on providing tailored solutions, Quay Pharma aids in the progression of pharmaceutical products from the initial stages of development through to commercial production.
Services include:
– Active Pharmaceutical Ingredients
– Biopharmaceuticals
– Contract Manufacturing (CMO/CDMO)
– Finished Dosage Formulation
– Packaging
Quay Pharma is committed to delivering high-quality services that meet the diverse needs of the pharmaceutical industry. For more information, visit quaypharma.com.
Contact Information
Related Listings

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl










